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Cost-Effectiveness of Guidelines for Insertion of Inferior Vena Cava
Filters in High-Risk Trauma Patients
E. L. Spangler, E. D. Dillavou, and K. J. Smith, Pittsburgh, Pa
From the University of Pittsburgh.
Background: Inferior vena cava filters (IVCF) can prevent pulmonary
embolism (PE); however, indications for use vary. While the Eastern Asso-
ciation for the Surgery of Trauma (EAST) 2002 guidelines suggest prophy-
lactic IVCF use in high-risk patients, the American College of Chest Physi-
cians (ACCP) 2008 guidelines do not. This analysis compared the cost-
effectiveness of prophylactic vs therapeutic retrievable IVCF placement in
high-risk trauma patients.
Methods: A Markov model was created to determine incremental
cost-effectiveness of these guidelines in dollars per quality-adjusted life-years
(QALYs) by accounting for costs and utilities of events occurring during
hospitalization and long-term follow-up. Our population was 46-year-old
trauma patients at high risk for venous thromboembolism (VTE) by EAST
criteria to whom either the EAST (prophylactic IVCF) or ACCP (no
prophylactic IVCF) guidelines were applied. The analysis assumed the
societal perspective over the patient’s lifetime, using a 1-day cycle length.
For base case and sensitivity analyses, event probabilities and utilities were
obtained from published literature, and costs calculated from the Center for
Medicare and Medicaid Services (CMS) fee schedules, the Healthcare Cost
and Utilization Project database, and Redbook wholesale drug prices for
2007; for data not available from the literature, assumptions were set forth
based on similarities to other populations.
Results: In base case analysis, prophylactic IVCFs were not cost-
effective, being bothmore costly ($37,700 vs $37,300) and less effective (by
0.139 QALYs) than therapeutic IVCFs. Results were sensitive to several
probabilities; the cost-effectiveness of prophylactic IVCFs varied signifi-
cantly with probabilities of late venous thromboembolism (VTE) and com-
plications related to anticoagulation. Prophylactic IVCFs were less effective,
but less costly when the probability of late VTE was 4.3% per year (base
case, 4.6%) among those with a removed filter, or5.1% per year (base case,
6.1%) among those with a retained filter. The probability of anticoagulation
complications, primarily gastrointestinal bleeding, was assumed to be the
same in individuals with removed filters and individuals who never had a
filter. Prophylactic filters were less effective, but less costly when the proba-
bility of anticoagulation complications among those with a removed filter or
who never had a filter was 3.9% per year (base case, 2.5%). Prophylactic
filters were less effective andmore costly over the range of probabilities in the
literature of anticoagulation complications for individuals with a retained
filter (base case, 2.1%/y).
Conclusions: Our analysis suggests prophylactic IVC filters are not
cost-effective. This result is dependent on probabilities of long-term se-
quelae (VTE, bleeding complications) that are poorly characterized in the
literature due to the recent advent of retrievable filters and lack of long-term
follow-up in patients with retained and removed filters.
Large Vein Reconstruction with Oncologic Procedures
M. A. Mansour, B. Wheatley, J. M. Gorsuch, C. A. Chambers, and
R. F. Cuff, Grand Rapids, Mich
From Michigan State University.
Background: Tumor proximity or invasion of large venous structures
in the abdomen frequently requires resection or reconstruction of large
veins. This study reviewed the outcomes of large vein reconstruction in
conjunction with surgical resection of intra-abdominal tumors.
Methods: In a 5-year period, 16 patients (2 women, 14 men) pre-
sented for resection of intra-abdominal malignancy. The average patient age
was 57 years (range, 41-67 years). Tumor proximity or invasion of large
venous structures was detected on preoperative computed tomography
(CT) scan. The groins were prepared in the surgical field to facilitate
harvesting of the great saphenous vein, if necessary. Venous reconstruction
with primary resection and reanastomosis or saphenous panel graft was
performed in all cases except one, where the entire infrarenal inferior vena
cava (IVC) was replaced with a polytetrafluoroethylene graft. Follow-up
imaging was done in all patients 3 months.
Results: Resection of tumors invading or adjacent to IVC was done in
eight patients, portal vein in seven, and iliac vein in one. For the IVC
patients, tissue pathology was renal cell carcinoma in five, leiomyoma in two,
and recurrent testicular cancer in one. Pancreatic adenocarcinoma caused all
the portal vein cases. Extracorporeal femoral–axillary venovenous bypass was
performed in three patients to help venous return during clamping. One
patient required hypothermic circulatory arrest to resect an intravascular
tumor that extended from the right iliac vein to the atrium. Reconstruction
of the portal vein was with primary repair in four and paneled saphenous vein
in three. The IVC was primarily repaired in all but one patient. The iliac vein
was repaired with paneled saphenous vein graft. All patients were alive in the
average follow-up period of 9 months (range, 1-60 months). The patient
with the prosthetic graft presented with a duodenal leak and graft infection
necessitating graft excision at 4 weeks. Recurrent pancreatic cancer was
detected in three patients. All venous structures except one were patent in
follow-up.
Conclusions: Large vein reconstruction is required in a small number
of patients to restore venous continuity. Primary repair or bypass with
autogenous graft is preferable to ligation or prosthetic graft. Most venous
reconstructions remain patent without any special anticoagulation.
Post-Menopausal Leg Swelling
S. Raju,a M. Oglesbee,b and P. Neglen,b Jackson and Flowood, Miss
From theUniversity ofMississippiMedical Center, Jacksona; and River Oaks
Hospital, Flowood.b
Background: Leg swelling after menopause is common. The prevail-
ing concept in primary care is that it is polycentric and a treatable cause may
not be found. Traditional systemic causes may be investigated, but venous
etiology is rarely considered. Patients are prescribed empiric diuretics, often
without benefit. Our clinical experience indicates that iliac venous vein
obstruction is frequently the core cause. A variety of secondary factors that
are common in the postmenopausal life stage (eg, joint surgery, onset of
venous reflux, venosclerosis, seated orthostasis) disturb the precarious re-
gional fluid balance and precipitate swelling. Postulated but undefined
hormonal and metabolic imbalances may be contributory.
Methods: Intravascular ultrasound (IVUS)-guided vein stenting im-
aging was done in 310 limbs of 256 postmenopausal women (aged 55
years) with leg swelling unresponsive to conservative therapy (49 with
concurrent endovenous laser therapy) during an 11-year period. The group
constituted 18% of the 1760 limbs with chronic venous disease stented
during the same period and 34% of those stented for swelling. Median age
was 66 years (range, 55-92 years) and the left/right ratio was 3:1.
Results: Obstruction was primary in 65% and post-thrombotic in 35%
of limbs. Thirty-one percent of limbs had obstruction only and 69% com-
bined obstruction and reflux: 32% had superficial reflux, 10% deep reflux,
and 24% had both. Axial reflux was present in 8%. Lymphatic dysfunction
was present in 13% of the limbs. Mean IVUS area stenosis was 70%  20%
(SD). The 30-day mortality was nil. Deep venous thrombosis occurred in
seven limbs 30 days and in five others later (overall, 4%). Mean follow-up
was 19  22 months (range, 1-120 months). Secondary stent patency at 6
years was 100% in primary and 78% in post-thrombotic limbs (91% overall).
Five of 14 stents that occluded were reopened. Swelling improved signifi-
cantly (P  .0001) from preoperative grade 2  1 to postoperative grade
1  1.2. Associated pain also improved significantly (P  .0001) from
preoperative VAS 4  3 to postoperative 0.6  1.7. Scores on the Chronic
Venous Insufficiency Quality of Life Questionnaire improved significantly
(P .0001) in every category (pain, work, sleep, social, morale) and overall
(from 66  20 preoperative to 49  22 postoperative; P  .0001).
Conclusions: Patients with post-menopausal leg swelling frequently
have obstructive venous pathology and two-thirds have associated reflux.
Morbidity arises from painful swelling that retards mobility and compro-
mises ability of self-care at a frail stage of life. Characteristic clinical features
and pathology should qualify this large subset as a distinct clinical entity.
Outpatient percutaneous iliac vein stenting alone or with concurrent saphe-
nous ablation affords substantial symptom relief and improvement in quality
of life measures. Greater clinical awareness among primary care physicians is
essential to serve this otherwise neglected patient population.
Neonatal and Adult Dermal Fibroblasts Show Differences in Transform-
ing Growth Factor (TGF-) Secretion and TGF- Type II Receptor
Expression at Baseline and Under Constant Stretch Conditions
C. Glass, J. Cullen, E. Roztocil, C. Doan, G. Augustin, K. Illig, M. Singh,
and D. Gillespie, Rochester, NY
From the University of Rochester.
Background: Previous investigations in dysregulation of tissue fibrosis
seen in chronic venous insufficiency (CVI) have used commercially available
neonatal fibroblasts (nn-fbs) as controls. Adult fibroblasts (a-fbs) are com-
mercially available but have not been used as controls to study venous
disease, which occurs predominantly in the adult population. In an effort to
investigate if transforming growth factor (TGF)- alterations occur as a
normal process in healthy aging fibroblasts, we examined TGF-, TGF-RI,
and TGF-RII expression between commercial nn-fbs and a-fbs. We also
attempted to determine if there were any differences in response to mechan-
ical stress between healthy nn-fbs and a-fbs.
Methods: Confluent early passage (P3-P5) nn-fbs and a-fbs were
cultured. Flow cytometry by fluorescence activated cell sorting (FACS) was
performed to determine basal levels of TGF-RI-positive and TGF-RII-
positive cells and receptor density measured by mean fluorescent intensity
(MFI). Basal levels of secreted TGF- were quantified using enzyme-linked
immunosorbent assay (ELISA). To mimic the increased stretch to which
dermal fibroblasts are exposed to in patients with CVI, nn-fbs and a-fbs were
cultured on collagen-coated Flexplates, and subjected to constant equibi-
axial elongation (21%) for 24 hours using a Flexercell strain unit. Cells and
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media were harvested. TGF- secretion in response to stress was determined
by ELISA.
Results: No difference was noted in the number of TGF-RI-positive
and TGF-RII-positive cells between a-fbs and nn-fbs; however, TGF-RII
density was reduced 40% as determined by MFI in a-fbs compared with
nn-fbs (151 25 vs 51 27, n 6; P .03). In healthy commercial nn-fbs
subjected to constant mechanical stress for 24 hours, there was no change in
TGF- secretion compared with the static (control) nn-fbs. However, there
was a fourfold increase in TGF- secretion (284  133 vs 1076  238
pg/mL, n  4; P  0.03) in a-fbs exposed to mechanical stress compared
with their control.
Conclusions: Previous studies investigating venous ulcer fibroblasts
have shown alterations of TGF-  and their receptors. This study reveals that
these alterations may occur as part of the normal aging process as demon-
strated by baseline differences seen between nn-fbs and a-fbs. Furthermore,
a-fbs should be considered for use as controls because they possess normal
age-specific characteristics that maymore closely reflect venous disease in the
adult population.
Post-Thrombotic Vein Wall Remodeling: Preliminary Findings
K. Deatrick, N. Baker, S. DeRoo, M. A. Elfline, V. Sood, C. Stabler,
S. A. Blackburn, C. E. Luke, T. W. Wakefield, and
P. K. Henke, Ann Arbor, MI
From the University of Michigan.
Background: Post-thrombotic syndrome (PTS) is characterized by a
fibrotic vein injury after deep vein thrombosis (DVT), resulting in a less
compliant vein wall. We sought to quantify the change in vein wall thickness
and to determine if vein wall damage, defined as wall thickening, is worsened
in patients when DVT fails to resolve by 6 months, and also whether there
were differences in blood or plasma levels of proteins associated with tissue
remodeling.
Methods: Patients presenting with suspected lower extremity DVT
were evaluated. Ultrasound imaging of the lower extremity venous system
was performed, and blood was collected. Patients with DVT received repeat
evaluation with blood draw and ultrasound imaging at 6 months. DVT
resolution was assessed using ultrasound examination. The thickness of the
vein wall was quantified by ultrasound imaging in each segment affected by
thrombus, and a contralateral, unaffected vein wall served as a control.
Messenger RNA was extracted from whole blood using the PAXgene
system, and serum proteins were analyzed using enzyme-linked immunosor-
bent assay (ELISA). Analysis of variance or t tests were used. P  .05 was
significant.
Results: Thirty patients (10 with DVT resolution at 6 months, 10 with
persistent thrombus, and 10 healthy controls) were compared. Resolving
and nonresolving DVT were both associated with 1.5- to 1.8-fold increased
vein wall thickness at 6 months (n  10-12; P  .008) compared with
nonaffected vein wall segments. However, the thickness of the affected
segments was 1.4-fold greater in patients who had total resolution of the
DVT by 6 months than in patients who had persistent chronic thrombus 6
months after presentation (n  10-12; P  .01,). There was a four- to
fivefold increased level of MMP-9 in all thrombosed groups compared with
controls (n  5; P  .05). Toll-like receptor-9 (TLR-9) expression was
threefold less than in controls (n  5; P  .05). There were no statistically
significant differences in the levels of associated factors such as D-dimer,
P-selectin, or inflammatory and remodeling markers such as SLC or matrix
metalloproteinase (MMP)-2 by ELISA. There were no significant differ-
ences in the gene expression of C-reactive protein, MMP-2, MMP-9, or
TLR-4.
Conclusions: This preliminary study suggests ongoing vein wall re-
modeling after DVT. At 6 months, the vein wall is markedly thickened, but
this change is independent of thrombus resolution and is associated with
elevatedMMP-9 but not other inflammatory markers. This suggests that the
vein wall damage is initiated early after thrombus formation and persists even
in the presence of total resolution.
Development of a Questionnaire to Evaluate the Burden of Chronic
Venous Disease in Daily Life
J. Guex Sr,a N. Rahhali Jr,b and C. Taieb Jr,b Nice and Boulogne, France
From SFP, Nicea; and PFSA, Boulogne.b
Background: In a difficult economic context, the burden of chronic
diseases is becoming a greater concern for public health authorities. Health
care professionals and institutions need an evaluation tool to assess objec-
tively the burden of chronic venous disorders and its consequences. This
study is a very preliminary approach.
Methods: A questionnaire was developed according to a strict meth-
odologic process to guarantee its credibility and reliability. A literature
review and face-to-face interviews enabled the identification of 66 items
linked to the pathology. Items were reduced to 36 after evaluation and
suppression of redundant, nonspecific, and nonsensitive items.
Results: Exploratory evaluations have shown that the concept of
burden could be structured around six aspects: pain, daily life, family and
personal relationships, work, psychologic effect, and treatment by a general
practitioner. For a complete evaluation of the burden, evaluation of these six
aspects was complemented with three visual analog scales (VAS): psycholog-
ical, physical, and living with the disease. The Assessment of Burden in
Chronic–Venous (ABC-V) Disorders questionnaire was administered to
individuals consulting spontaneously for CVD with a phlebologist, who
confirmed the CVD. Eight centers throughout France recruited 328 indi-
viduals: 82.7% were women (average age, 54.6  13 years), 59% had a
professional activity, and 32% were overweight or obese according to the
body mass index. The correlations between the ABC-V score and the
Specific Quality of Life and Outcome Response – Venous (SQOR-V and
Center for Epidemiologic Studies Depression Scale (CES-D)scores (recog-
nized and validated questionnaires) were sought. The ABC-V score is highly
positively correlated to SQOR-V and CES-D scores. The three aspects with
the greatest impact on the burden were the Pain, Physical, and Living with
the Disease VAS. The two aspects with the lowest impact on the burden are
Treatment by GP and Family Life (Table).
Conclusions: Chronic pathologies such as venous disease remain
frequent and crippling diseases that are difficult to assess with only clinical
elements or QOL instruments because the effect can be multidimensional.
Several existing questionnaires attempt to evaluate one or another of these
aspects. The ABC-V takes them all into consideration to express the global
nature of the handicap and burden of chronic diseases.
ANovelMethod ofMeasuringHuman Lymphatic Pumping inHealthy
and Lymphedematous Legs Using Indocyanine Green Fiuorescence
Lymphography
N. Unno,a M. Nishiyama,a M. Suzuki,a N. Yamamoto,a H. Tanaka,a
D. Sagara,a Y. Mano,a Y. Mano,a M. Sano,a and H. Konno,b Hamamatsu,
Japan
From the Division of Vascular Surgery,a and Second Department of Sur-
gery,b Hamamatsu University School of Medicine.
Background: The lymphatic system possesses numerous active pumps
to propel lymph to the central lymphatic systems. Decreased pumping
activity may be associated with lymphedema. However, there are no nonin-
vasive methods to measure lymphatic pump force in clinical practice. The
aim of this study was to introduce a new method to measure lymphatic
pumping and compared the activity between healthy and lymphedematous
legs using indocyanine green (ICG) fluorescence lymphography.
Methods: ICG fluorescence lymphography was performed by subcu-
taneously injecting 0.3mL of ICG (10% in normal saline) into the dorsum of
the foot. Fluorescence images were obtained with an infrared-light camera
system in a supine position. Sphygmomanometer cuffs were wrapped around
the lower legs and connected to a standard mercury sphygmomanometer.
The cuffs were inflated to 60 mm Hg, then, gradually deflated to lower the
pressure by 10-mm Hg steps until the fluorescence dye exceeded the upper
border of the cuff, when the lymphatic contraction overcame the cuff
pressure. The value of the cuff pressure was taken as lymph pumping pressure
(Ppump; Fig 1). In nine volunteers without swollen legs (18 legs), we
compared the Ppump obtained with ICG fluorescence lymphography with
that obtained from dynamic lymphoscintigraphy. With dynamic lympho-
scintigraphy, Ppump was measured from the time-activity curves using the
same sphygmomanometer cuff technique (Fig 2). With ICG fluorescence
lymphography, we compared Ppump between 27 healthy volunteers (54
legs) and 22 lymphedema patients (26 swollen legs).
BVD, Burden of vascular disease; SD, standard deviation; VAS, visual analog
scale.
Fig. Assessment of Burden in Chronic-Venous results
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